208 related articles for article (PubMed ID: 9759557)
1. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate.
Rittenhouse HG; Finlay JA; Mikolajczyk SD; Partin AW
Crit Rev Clin Lab Sci; 1998 Aug; 35(4):275-368. PubMed ID: 9759557
[TBL] [Abstract][Full Text] [Related]
2. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
[TBL] [Abstract][Full Text] [Related]
3. Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling.
Bridon DP; Dowell BL
Urology; 1995 May; 45(5):801-6. PubMed ID: 7538242
[TBL] [Abstract][Full Text] [Related]
4. Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells.
Kumar A; Mikolajczyk SD; Hill TM; Millar LS; Saedi MS
Prostate; 2000 Aug; 44(3):248-54. PubMed ID: 10906742
[TBL] [Abstract][Full Text] [Related]
5. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
[TBL] [Abstract][Full Text] [Related]
6. Polyclonal and monoclonal antibodies to prostate-specific antigen can cross-react with human kallikrein 2 and human kallikrein 1.
Finlay JA; Day JR; Rittenhouse HG
Urology; 1999 Apr; 53(4):746-51. PubMed ID: 10197850
[TBL] [Abstract][Full Text] [Related]
7. Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivity.
Lövgren J; Piironen T; Overmo C; Dowell B; Karp M; Pettersson K; Lilja H; Lundwall A
Biochem Biophys Res Commun; 1995 Aug; 213(3):888-95. PubMed ID: 7544581
[TBL] [Abstract][Full Text] [Related]
8. Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels.
Charlesworth MC; Young CY; Klee GG; Saedi MS; Mikolajczyk SD; Finlay JA; Tindall DJ
Urology; 1997 Mar; 49(3):487-93. PubMed ID: 9123724
[TBL] [Abstract][Full Text] [Related]
9. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2.
Lövgren J; Rajakoski K; Karp M; Lundwall â ; Lilja H
Biochem Biophys Res Commun; 1997 Sep; 238(2):549-55. PubMed ID: 9299549
[TBL] [Abstract][Full Text] [Related]
10. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity.
Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG
Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595
[TBL] [Abstract][Full Text] [Related]
11. Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2.
Klee GG; Goodmanson MK; Jacobsen SJ; Young CY; Finlay JA; Rittenhouse HG; Wolfert RL; Tindall DJ
Clin Chem; 1999 Jun; 45(6 Pt 1):800-6. PubMed ID: 10351988
[TBL] [Abstract][Full Text] [Related]
12. Human prostate-specific glandular kallikrein is expressed as an active and an inactive protein.
Herrala A; Kurkela R; Porvari K; Isomäki R; Henttu P; Vihko P
Clin Chem; 1997 Feb; 43(2):279-84. PubMed ID: 9023130
[TBL] [Abstract][Full Text] [Related]
13. Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells.
Saedi MS; Zhu Z; Marker K; Liu RS; Carpenter PM; Rittenhouse H; Mikolajczyk SD
Int J Cancer; 2001 Nov; 94(4):558-63. PubMed ID: 11745444
[TBL] [Abstract][Full Text] [Related]
14. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
[TBL] [Abstract][Full Text] [Related]
15. Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases.
Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Saeid MS; Young CY; Klee GG; Tindall DJ; Bostwick DG
Urology; 1999 May; 53(5):939-44. PubMed ID: 10223487
[TBL] [Abstract][Full Text] [Related]
16. Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections.
Siivola P; Pettersson K; Piironen T; Lövgren T; Lilja H; Bjartell A
Urology; 2000 Oct; 56(4):682-8. PubMed ID: 11018639
[TBL] [Abstract][Full Text] [Related]
17. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
[TBL] [Abstract][Full Text] [Related]
18. Expression of human glandular kallikrein, hK2, in mammalian cells.
Kumar A; Goel AS; Hill TM; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Saedi MS
Cancer Res; 1996 Dec; 56(23):5397-402. PubMed ID: 8968092
[TBL] [Abstract][Full Text] [Related]
19. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen.
Black MH; Magklara A; Obiezu CV; Melegos DN; Diamandis EP
Clin Chem; 1999 Jun; 45(6 Pt 1):790-9. PubMed ID: 10351987
[TBL] [Abstract][Full Text] [Related]
20. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
